Point-of-Care Test Measures Response to Clopidogrel

December 30, 2009

The T-Guide diagnostic test assesses patient response to clopidogrel to screen for the 30 percent of patients who do not respond to the anti-platelet drug. The simple, inexpensive, disposable test kit is designed for point-of-care use. It enables nontechnical staff to run the tests in physicians' offices and clinics.

For more information: www.thrombovision.com

Your name: *

E-mail: *

The content of this field is kept private and will not be shown publicly.

Homepage:

Subject:

Comment: *

Input format

Filtered HTML

Web page addresses and e-mail addresses turn into links automatically.
Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd><p><br>

Full HTML

Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

More information about formatting options

By submitting this form, you accept the Mollom privacy policy.

May 23, 2013 — Syntermed Inc. has been awarded 510(k) clearance for Emory Cardiac Toolbox version 4.0.

Intermountain Launches Nation’s First System to Measure, Report Cumulative Medical Radiation Exposure

May 23, 2013 — Intermountain Healthcare, a Utah-based nonprofit system of 22 hospitals and 185 clinics, is compiling the...

Common Drug Can Limit Radiation Damage to Cancer Patient’s Heart, Lungs

May 21, 2013 — Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can...

View all

Syntermed Awarded 510(k) Clearance for Cardiac Imaging Decision Support System